RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer.

RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Dec; 25(8):e411-e419.

View in: PubMed

subject areas

Adult
Aged
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Prognosis
RNA-Binding Proteins
Survival Rate

authors with profiles

Ravi Salgia